Oral beta-hydroxybutyrate alleviates COVID-19 related acute respiratory distress syndrome: A randomized, single-blind, placebo-controlled trial.
Navid Reza ShahtaghiSamira BigdelitabarSubham ThakurManjot KaurHarjeet SinghMuskaan SainiManjinder SinghKanwardeep SinghSubheet Kumar JainPublished in: Research in social & administrative pharmacy : RSAP (2024)
(http://ctri.nic.in/CTRI/2021/03/031790).